PATENT CLAIM ANALYSIS

Application Number: 16172100
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "649000"]

Abstract:
A hitherto unknown crystalline form of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride, pharmaceutical compositions containing the new crystalline form, methods of producing the new crystalline form, and a related method of use including treatment of, e.g., pain and/or urinary incontinence.

Claim (Index 7):
The process according to  claim 1 , further comprising redissolving the (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride of crystalline Form A in a solvent selected from acetone, acetonitrile and isopropanol, then optionally filtering the solution to remove any insoluble residue and optionally reducing the amount of solvent by evaporation, then allowing the solution to crystallize.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.51429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12634777', '12329111', '12016506', '12850208', '15033331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7151492213166573
- 35 USC 102 Novelty (BERT): 0.5701646142018261
- Combined Prediction Score: 0.7006507606051742
- Mean Citation Score: 271.66068
- Max Citation Score: 446.01437
- Similarity Product: 376.19382880930425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test